ELQ-598, as a prodrug, is converted into the active drug ELQ-596 upon oral administration. ELQ-598 demonstrates potent parasitic growth inhibition capabilities (IC50= 37 nM). ELQ-598 also shows low toxicity towards human cells (IC50= 19 µM). ELQ-598 can be used for research into babesiosis[1].
Molecular Weight:
561.93
CAS Number:
[3023709-99-8]
Formula:
C28H23ClF3NO6
Target:
Parasite
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted
